Skip to content

Evaluation of the effect of Intravenous dexamethasone vs. ketamine gargle vs. intravenous dexamethasone combined with ketamine gargle on post operative sore throat and hoarseness

Evaluation of the effect of Intravenous dexamethasone vs. ketamine gargle vs. intravenous dexamethasone combined with ketamine gargle on post operative sore throat and hoarseness

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201305165362N5
Enrollment
140
Registered
2013-06-12
Start date
2011-10-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: acute sore throat. Condition 2: hoarseness. Acute pharyngitis, unspecified Dysphonia

Interventions

Intervention 1: Group K, who gargled 40mg ketamine in 30 ml normal saline for 30 s and received 2mg/kg intravenous saline, 5 min before induction anesthesia. Intervention 2: Group D, who gargled 30ml
Prevention
Group K, who gargled 40mg ketamine in 30 ml normal saline for 30 s and received 2mg/kg intravenous saline, 5 min before induction anesthesia.
Group D, who gargled 30ml normal saline for 30 s and received 0.2mg/kg intravenous dexamethasone, 5min before induction anesthesia.
Group KD, who gargled 40 mg ketamine in 30 ml normal saline and received 0.2mg/kg intravenous dexamethasone, 5min before induction anesthesia.
Group P who received a placebo of normal saline (gargled 30 ml normal saline for 30 s and received 0.2mg/kg intravenous normal saline, 5min before induction of anesthesia).

Sponsors

Anesthesiology and Critical Care Research Center,Isfahan University of Medical Sciences, Isfahan, Ir
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients without a history of preoperative sore throat and asthma;Patients without recent NSAID medication; mouth opening of >3.5cm;a Cormack score of lower than 4; patients with duration of surgery between 60-300 min ;known allergies to study drugs; known difficulty with tracheal intubation. Exclusion criteria were: Those who required more than one attempt for tracheal intubation; Patients with the requirement of mechanical lung ventilation after surgery in the intensive care unit.

Exclusion criteria

Exclusion criteria:

Design outcomes

Secondary

MeasureTime frame
Recovery time(min). Timepoint: times from discontinuation of anesthesia until the time to achieve a modified Aldrete score of 9. Method of measurement: aldrete score.;The duration of tracheal intubation. Timepoint: the duration of tracheal intubation. Method of measurement: watching.;Sedation. Timepoint: during interviewed the patients to investigate the POST(post operative sore throat) (0,2,4,8,16,24h after tracheal extubation). Method of measurement: using the four-point Observer’s Assessment of Alertness/ Sedation (OAA/S) scale (where 0 = awake/alert and 3 = deep sleep).

Primary

MeasureTime frame
Sore throat. Timepoint: On arrival in the post-anesthesia care unit (0 h), and at 2, 4, 8,16and 24 h thereafter,. Method of measurement: 0, no sore throat; 1, mild sore throat (complains of sore throat only on asking); 2, moderate sore throat (complains of sore throat on his/her own); and 3, severe sore throat (change of voice or hoarseness, associated with throat pain).;Hoarseness. Timepoint: On arrival in the post-anesthesia care unit (0 h), and at 2, 4, 8,16and 24 h thereafter,. Method of measurement: watching-0, No hoarseness; 1, Hoarseness at the time of interview, but noted only by patient; 2, Hoarseness that is readily apparent, but mild; 3, Hoarseness that is readily apparent and severe.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Azim Honarmand

Isfahan University of Medical Sciences, Isfahan, Iran

Honarmand@med.mui.ac.ir+98 311

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026